DelSiTech is excited to announce our participation in the annual Drug Delivery & Formulation (DDF) Summit, to be held in Berlin on June 27 – 29th, 2022.
The DDF summit brings together formulation specialists, leading associated technologies, and pharmaceutical industry innovators to share insights for improving deliverability, continuous manufacturing, developing solutions for patient compliance, solutions to challenging routes of administration, controlled release technologies and much more, in the context of both small molecules and biological entities.
DelSiTech, as a leading developer of long-acting controlled release formulations for both small molecules and biological entities, across both parenteral and topical routes of administration, is pleased to be presenting at the event. Dr. Frederic Dargelas, Director, Head of Business Development and Alliance Management at DelSiTech will present on “Controlled and Long-Acting Release for Ophthalmic and Sub-cutaneous Administration with Biodegradable DelSiTech Silica Matrix Technology“. The session will be held at 12:25-13.00pm (CET) as part of the “Solutions Spotlight – Technology & Innovation” and we encourage you to join in to learn more about ophthalmic and sub-cutaneous drug delivery by Silica Matrix.